A Transcatheter aortic valve replacement (TAVR), also known as Transcatheter aortic valve implantation (TAVI) is a minimally invasive surgical process that treats the aortic valve by substituting a new biological valve into the old aortic valve?s place without removing the damaged valve. The transcatheter aortic valve replacement (TAVR) market is estimated to grow from USD 7.04 billion in 2022 to USD 22.72 billion by 2028 at a CAGR of 21.19% during the forecast period.
Iwin Iwin
5th Ave Flooring
Leonard Barbo Violins
Thrane Song
Vistisen Gaines
Mckinney Hahn
Burnette Lane
Iwin Iwin
Odonnell Downey
Wiese Malling